Literature DB >> 2843312

Plasma levels of atrial natriuretic peptide in hyperthyroidism.

A S Woolf1, P J Moult.   

Abstract

We measured plasma atrial natriuretic peptide (ANP) levels in 17 patients with newly diagnosed thyrotoxicosis. ANP was elevated compared to a group of healthy controls and fell to normal after treatment. Plasma cyclic guanosine monophosphate was also raised in untreated patients. Elevated circulating levels of ANP may play a part in the haemodynamic changes of hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2843312     DOI: 10.1111/j.1365-2265.1987.tb02956.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Plasma concentrations of atrial natriuretic peptide in hypothyroidism.

Authors:  A S Woolf; P J Moult
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

2.  The effects of low dose intravenous 99-126 atrial natriuretic factor infusion in patients with chronic renal failure.

Authors:  A S Woolf; M A Mansell; B I Hoffbrand; S L Cohen; P J Moult
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

3.  Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.

Authors:  S Czekalski; K Widecka; J Gozdzik; K Ciechanowski; B Krzyzanowska-Swiniarska; E Gromniak; M Gruszczynska
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.